vaginal-microbiome

Evvy raises $40M as it seeks to further women’s health research with vaginal microbiome data

Women’s health startup Evvy announced a $40 million Series B round led by Catalio Capital Management to scale its vaginal microbiome testing and research. The company, founded in 2021, operates an at-home, CLIA- and CLEP-certified metagenomic sequencing test that users submit by mail for clinician-reviewed results and care guidance.